2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Presidential Session

[PS3] Presidential Session 3
【E】

Fri. Feb 18, 2022 8:20 AM - 10:35 AM Room 1 (Main Hall, 1F, Kyoto International Conference Center)

Chair:Chikashi Ishioka(Department of Clinical Oncology, Tohoku University Graduate School of Medicine),Ian Chau(Department of Medicine, Royal Marsden Hospital, London&Surrey, United Kingdom)
Discussant:Sun Young Rha(Yonsei Cancer Center, Yonsei University),Yasuo Hamamoto(Keio Cancer Center, Keio University School of Medicine),Ian Chau(Department of Medicine, Royal Marsden Hospital, London &Surrey, United Kingdom),Kenro Hirata(Cancer Center, Keio University),Zev A. Wainberg(UCLA School of Medicine),Kentaro Yamazaki(Shizuoka Cancer Center Division of gastrointestinal oncology),Eric Van Cutsem(University Hospitals Gasthuisberg / Leuven & KULeuven),Hironaga Satake(Department of Medical Oncology, Kochi Medical School),Yoo Changhoon(Asan Medical Center),Etsuro Hatano(Department of Surgery, Graduate School of Medicine, Kyoto University)

[PS3-1] First-line nivolumab plus ipilimumab or chemotherapy for advanced ESCC: A Japanese subanalysis of CheckMate 648

Takashi Ogata1, Yuichiro Doki2, Ken Kato3, Satoru Motoyama4, Hisato Kawakami5, Masaki Ueno6, Takashi Kojima7, Toshiyoshi Fujiwara8, Morihito Okada9, Ryu Ishihara10, Yutaro Kubota11, Xynos Ioannis12, Yasuhiro Matsumura13, Yuko Kitagawa14 (1.Kanagawa Cancer Center, 2.Osaka University Graduate School of Medicine, 3.National Cancer Center Hospital, 4.Akita University Graduate School of Medicine, 5.Kindai University Faculty of Medicine, 6.Toranomon Hospital, 7.National Cancer Center Hospital East, 8.Okayama University Hospital, 9.Hiroshima University Hospital, 10.Osaka International Cancer institute, 11.Showa University Hospital, 12.Bristol-Myers Squibb, 13.ONO Pharmaceutical Company Ltd., 14.Keio University School of Medicine)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password